SSSarangthem Dinamani Singh

Sarangthem Dinamani Singh

*This is an algorithmically generated author record based on publicly available information.

Sarangthem Dinamani Singh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Anju Singh

    Nucleic Acids Research Lab, Department of Chemistry, University of Delhi (North Campus), Delhi 110007, India

    1 shared publication
  • Gurpreet Kaur Grewal

    Department of Molecular Biology and Genetic Engineering, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, 144411, Punjab, India.

    1 shared publication
  • Malhar Desai

    Department of Molecular Biology and Genetic Engineering, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, 144411, Punjab, India

    1 shared publication
  • Ritushree Kukreti

    Genomics and Molecular Medicine Unit, Institute of Genomics and Integrative Biology (IGIB), Council of Scientific and Industrial Research (CSIR), Delhi 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India

    1 shared publication
  • Selvaraman Nagamani

    Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, 785006, Assam, India

    1 shared publication
  • Shrikant Kukreti

    Nucleic Acids Research Lab, Department of Chemistry, University of Delhi (North Campus), Delhi, 110007, India

    1 shared publication

Latest Publications

  • Open Access

    Decoding the relationship between oxidative stress and antiseizure medications using network pharmacology and molecular docking

    by Malhar Desai, Sarangthem Dinamani Singh, Selvaraman Nagamani, Sunik Malik, Anju Singh, Ritushree Kukreti, Shrikant Kukreti, Gurpreet K. Grewal

    Oxidative stress is known to be associated with epilepsy, and antiseizure medication treatment, albeit with limited consensus on the specific oxidative stress pathways/proteins involved. Identifying these can reveal novel therapeutic targets for epilepsy management. This study utilized network pharmacology to identify potential protein targets of carbamazepine and valproic-acid that are implicated in oxidative stress and epilepsy, thereby highlighting their therapeutic potential. Drug targets for carbamazepine and valproic-acid were predicted using SuperPred/SwissTargetPrediction, while genes associated with epilepsy and oxidative stress were obtained from DisGeNET and GeneCards. Common proteins were identified, and a protein–protein interaction network was constructed using STRING, followed by analysis via Cytoscape. Hub proteins identified were EGFR, GSK3B, and STAT3 for carbamazepine, and PTGS2, mTOR, and TLR4 for valproic-acid. Molecular docking revealed a strong binding affinity of carbamazepine to its targets (ΔGbind > − 5 kcal/mol) and binding of valproic-acid to its targets (ΔGbind > − 3 kcal/mol), with PTGS2 showing the strongest interaction with valproic-acid (− 5.06 kcal/mol). These findings underscore EGFR, GSK3B, and STAT3, for carbamazepine and PTGS2, mTOR, and TLR4 for valproic-acid as pivotal therapeutic targets in oxidative stress-associated epilepsy. These identified proteins can be targeted by add on antioxidants to alleviate oxidative stress generated by chronic antiseizure medication.